Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Gut Flora Modulation for The Prevention of Pci-Related Myocardial Injury - A Randomized, Placebo Controlled, Double Blind, Investigator-Initiated, Single Centre, Preliminary Study

NCT02908776 is registered in ClinicalTrials.gov with San Filippo Neri General Hospital as lead sponsor.

NCT NCT02908776
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02908776 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Gut Flora Modulation for The Prevention of Pci-Related Myocardial Injury - A Randomized, Placebo Controlled, Double Blind, Investigator-Initiated, Single Centre, Preliminary Study
Lead sponsor
San Filippo Neri General Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
September 30, 2016
Completion date
January 31, 2020
Enrollment
250 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic stable angina, periprocedural myocardial damage